Inhibitors | Comment | Organism | Structure |
---|---|---|---|
HP-RNase antibodies | affinity purified polyclonal antibodies against human pancreatic RNase. 94% inhibition with 50 ng | Homo sapiens | |
inhibit-Ace | 86% inhibition at 6 U/ml | Homo sapiens | |
ribonuclease inhibitor | RI, 97% inhibition at 6 U/ml | Homo sapiens |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
18000 | 26000 | gel filtration | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Posttranslational Modification | Comment | Organism |
---|---|---|
glycoprotein | different degrees of glycosylation. The N-glycosylation generates the molecular heterogeneity | Homo sapiens |
Purification (Comment) | Organism |
---|---|
gel filtration on SP-Sepharose column | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
umbilical vein endothelium | primary culture, HUVEC | Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
poly(C) + H2O | 35 times more active than with poly(U) | Homo sapiens | 3'-CMP + 3'-phosphooligonucleotides | - |
? | |
poly(U) + H2O | - |
Homo sapiens | 3'-UMP + 3'-oligonucleotides | - |
? | |
RNA + H2O | wheat germ RNA | Homo sapiens | 3'-phosphomononucleotides + 3'-phosphooligonucleotides | - |
? |
Synonyms | Comment | Organism |
---|---|---|
EC-RNase | - |
Homo sapiens |